相关实验视频

Updated: Jun 21, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

探索与过氧酶增殖器激活受体玛 (PPARγ) 调制剂相关的抗糖尿病治疗药物的指纹:一种化学建模方法

Subham Dawn¹, Prabir Manna¹, Totan Das²

¹Department of Pharmaceutical Technology, JIS University, 81, Nilgunj Road, Agarpara, Kolkata, West Bengal 700109, India.

Computational biology and chemistry

|July 14, 2024

概括

这项研究揭示了调节氧酶增殖器激活受体玛 (PPARγ) 活性的关键分子结构. 计算分析确定了开发有效PPARγ调节器的基本次结构特征.

科学领域:

药用化学医学化学
计算化学计算化学
药理学药理学是指药理学的学科.

背景情况:

过氧体增殖器激活受体玛 (PPARγ) 是代谢和炎症疾病的关键目标.
了解PPARγ调节器的结构-活性关系对于药物发现至关重要.

研究的目的:

确定与生物活性相关的氧酶增殖器激活受体玛 (PPARγ) 调节器的关键亚结构特征.
为新型PPARγ调节器的合理设计提供见解.

主要方法:

在323个PPARγ调节器的数据集上使用贝叶斯分类和递归分区 (RP).
进行分子对接和分子动力学模拟以验证发现.
集成多种计算方法来分析结构-活动关系.

主要成果:

确定了具有显著影响PPARγ调节活性的特定亚结构特征.
通过分子对接和动力学模拟证实了这些特征的重要性.
证明了调节器-PPARγ复合物的稳定性.

结论:

揭示了PPARγ调制所必需的关键结构动机.
这些发现为开发更有效的PPARγ调节器提供了基础.
这种计算方法为PPARγ调节器设计提供了深入的见解.

关键词:

糖尿病是一种糖尿病.他们的指纹是指纹.模拟MD的模拟方法分子对接是分子对接.在PPARγ调节器中.递归分区是指递归分区.

更多相关视频

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

相关概念视频

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...